Concordance of Flow Cytometry and Real-Time Quantitative Polymerase Chain Reaction for Measurable Residual Disease Detection in Childhood B-Cell Acute Lymphoblastic Leukemia: A Real-Life Data Analysis.
Objective Measurable residual disease (MRD) is the cornerstone of risk-adapted therapy in childhood B-cell acute lymphoblastic leukemia (B-ALL). In Türkiye, MRD assessment relies on flow cytometry (FCM), whereas molecular MRD is not routinely available. We aimed to evaluate the concordance between an experienced FCM la...